Results 31 to 40 of about 17,900 (168)
JA Clinical Reports, 2021 Background Drugs administered subcutaneously have delayed onset and prolonged duration of action versus those given intravenously. Since the duration of action of rocuronium is prolonged in patients with renal dysfunction, subcutaneous administration of ...
Akira Doshu-Kajiura +2 more
doaj +1 more source
Cells, 2021 Perioperative hypersensitivity (POH) to the neuromuscular blocking drug (NMBD) rocuronium was previously thought to be IgE and mast cell (MC)-mediated. However, the recent seminal observation that rocuronium induces degranulation in murine peritoneal MCs
Chalatip Chompunud Na Ayudhya +4 more
doaj +1 more source
Saudi Journal of Anaesthesia, 2013 Background: This survey aimed to assess the extent of practice of the Middle Eastern anesthesiologists in the use of neuromuscular blocking agents (NMB) in 2012.
Abdelazeem Eldawlatly +2 more
doaj +1 more source
Optimal precurarizing dose of rocuronium to decrease fasciculation and myalgia following succinylcholine administration [PDF]
Korean Journal of Anesthesiology, 2014 BackgroundSuccinylcholine commonly produces frequent adverse effects, including muscle fasciculation and myalgia. The current study identified the optimal dose of rocuronium to prevent succinylcholine-induced fasciculation and myalgia and evaluated the ...
Kyu Nam Kim +4 more
doaj +1 more source
Residual paralysis caused by 50 mg rocuronium after reversal with 4 mg/kg sugammadex: a case report
BMC Anesthesiology, 2021 Background Rocuronium-induced neuromuscular blockade can be quickly and completely reversed by administration of an optimal dose of sugammadex. Sugammadex antagonizes rocuronium-induced neuromuscular blockade by encapsulating rocuronium.
Kohji Uzawa +2 more
doaj +1 more source
Indian Journal of Animal Sciences, 2023 This study was executed in the clinical setup to investigate the effects of Rocuronium and its reversal by Neostigmine and Glycopyrrolate (Myopyrolate) combination in Propofol-Isoflurane anaesthetized dogs.
YUDHVIR RANA +9 more
doaj +1 more source
Effects of rocuronium, sugammadex and rocuronium-sugammadex complex on coagulation in rats
Brazilian Journal of Anesthesiology (English Edition), 2019 Abstract Background Sugammadex is an alternative pharmacological drug that is capable of reversing neuromuscular blockades without the limitations that are presented by anticholinesterase drugs. Coagulation disorders that are related to treatment with sugammadex were reported.
Cavalcanti, Ismar L. +6 more
openaire +7 more sources
The Kaohsiung Journal of Medical Sciences, EarlyView.ABSTRACT The study aimed to investigate the effect of thoracic paravertebral block (TPVB) with liposomal bupivacaine (LB) before anesthesia induction on postoperative pain, quality of recovery (QoR), and opioid consumption in older patients after video‐assisted thoracoscopic surgery (VATS).
Wen‐Cheng Shi +4 more
wiley +1 more source
Muscle &Nerve, EarlyView.ABSTRACT Thymoma is the most common tumor of the anterior mediastinum. Approximately 20%–30% of patients with a thymoma develop myasthenia gravis (MG), and an additional one third may possess positive acetylcholine receptor (AChR) antibodies without MG.
Benjamin Claytor +5 more
wiley +1 more source
Error Traps in Pediatric Neuromuscular Block
Pediatric Anesthesia, EarlyView.ABSTRACT Background Neuromuscular blocking agents are essential for safe pediatric anesthesia but remain a frequent source of preventable morbidity when misused, inadequately monitored, or incompletely reversed. Children, particularly neonates and infants, are especially vulnerable to residual neuromuscular block due to developmental pharmacological ...
Gabriel Soares de Sousa +5 more
wiley +1 more source